Your browser doesn't support javascript.
loading
Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma.
Choueiri, Toni K; Fishman, Mayer N; Escudier, Bernard; McDermott, David F; Drake, Charles G; Kluger, Harriet; Stadler, Walter M; Perez-Gracia, Jose Luis; McNeel, Douglas G; Curti, Brendan; Harrison, Michael R; Plimack, Elizabeth R; Appleman, Leonard; Fong, Lawrence; Albiges, Laurence; Cohen, Lewis; Young, Tina C; Chasalow, Scott D; Ross-Macdonald, Petra; Srivastava, Shivani; Jure-Kunkel, Maria; Kurland, John F; Simon, Jason S; Sznol, Mario.
Afiliação
  • Choueiri TK; Kidney Cancer Center, Dana-Farber Cancer Institute Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts. Toni_Choueiri@dfci.harvard.edu.
  • Fishman MN; Moffitt Cancer Center, Tampa, Florida.
  • Escudier B; Institut Gustave Roussy, Villejuif, France.
  • McDermott DF; Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Drake CG; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and the Brady Urological Institute, Baltimore, Maryland.
  • Kluger H; Yale University School of Medicine and Yale Cancer Center, New Haven, Connecticut.
  • Stadler WM; University of Chicago School of Medicine, Chicago, Illinois.
  • Perez-Gracia JL; Clinica Universidad de Navarra, Pamplona, Navarra, Spain.
  • McNeel DG; University of Wisconsin at Carbone Cancer Center, Madison, Wisconsin.
  • Curti B; Earle A. Chiles Research Institute, Portland, Oregon.
  • Harrison MR; Duke University Medical Center, Durham, North Carolina.
  • Plimack ER; Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Appleman L; University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania.
  • Fong L; University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California.
  • Albiges L; Kidney Cancer Center, Dana-Farber Cancer Institute, Boston, Massachusetts, and Institut Gustave Roussy, Villejuif, France.
  • Cohen L; Bristol-Myers Squibb, Princeton, New Jersey.
  • Young TC; Bristol-Myers Squibb, Princeton, New Jersey.
  • Chasalow SD; Bristol-Myers Squibb, Princeton, New Jersey.
  • Ross-Macdonald P; Bristol-Myers Squibb, Princeton, New Jersey.
  • Srivastava S; Bristol-Myers Squibb, Princeton, New Jersey.
  • Jure-Kunkel M; Bristol-Myers Squibb, Princeton, New Jersey.
  • Kurland JF; Bristol-Myers Squibb, Princeton, New Jersey.
  • Simon JS; Bristol-Myers Squibb, Princeton, New Jersey.
  • Sznol M; Yale University School of Medicine and Yale Cancer Center, New Haven, Connecticut.
Clin Cancer Res ; 22(22): 5461-5471, 2016 Nov 15.
Article em En | MEDLINE | ID: mdl-27169994

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article